Latest Intelligence on General Business in South Africa

Published within

« | 1 | 2 | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

HIV patents: no solution - yet

While the WTO has not yet made a breakthrough on the issue of patent-free HIV drugs for developing economies, something must be done to alleviate the human and economic cost of the HIV epidemic. Western pharma companies will inevitably lose out - the only question is how well their profit maintenance strategies can cushion the blow.

Published By Datamonitor
22 Oct 2002
CommentWire
CommentWire

Man Group: seeking diversification in derivatives

Man Group's purchase of leading derivatives broker GNI from Old Mutual will create the world's largest independent futures broker. Man Group has profited well from the growth in hedge funds to become a giant in this sector, but as demand for such alternative investment is weakening, diversifying away from its core business looks like a strong plan.

Published By Datamonitor
22 Oct 2002
CommentWire
CommentWire

Exel: acquire local, build global

Exel's latest purchase will boost its global air and sea freight activities, as well as strengthen its local operations in South Africa. While some global players are following an acquisition path designed to diversify their operations across the supply chain, Exel's strategy involves building its core logistics and freight capabilities on a global scale.

Published By Datamonitor
08 Nov 2002
CommentWire
CommentWire

African HIV: more research needed, says Mandela

According to Nelson Mandela, further research is required into the effects of antiretroviral drugs among African populations before they can be prescribed as a frontline HIV treatment. This is a good idea, but it is unlikely that the African market is large enough for drug makers to justify additional trials from a revenue standpoint. Instead, international financial support will be needed.

Published By Datamonitor
04 Dec 2002

« | 1 | 2 | » »|

No help is available.